Page 284 - Vitamin D and Cancer

11 Vitamin D and Hematologic Malignancies 271

34. Choudhuri U, Adams JA, Byrom N, McCarthy DM, Barrett J (1990) 1,25-Dihydroxyvitamin
D3 induces normal mononuclear blood cells to differentiate in the direction of monocyte-
macrophages. Haematologia (Budap) 23(1):9–19
35. Kreutz M, Andreesen R (Dec 15, 1990) Induction of human monocyte to macrophage matu-
ration in vitro by 1,25-dihydroxyvitamin D3. Blood 76(12):2457–61
36. Paquette RL, Koeffler HP (June 1992) Differentiation therapy. Hematol Oncol Clin North
Am 6(3):687–706
37. Grande A, Montanari M, Tagliafico E, Manfredini R, Marani TZ, Siena M, Tenedini E, Gallinelli
A, Ferrari S (Apr, 2002) Physiological levels of lalpha, 25 dihydroxyvitamin D3 induce the
monocytic commitment of CD34+ hematopoietic progenitors. J Leukoc Biol 71(4):641–51
38. Berer A, Stöckl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L (May,
2000) 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation
in vitro. Exp Hematol 28(5):575–83
39. Tobler A, Gasson J, Reichel H, Norman AW, Koeffler HP (June 1987) Granulocyte-
macrophage colony-stimulating factor. Sensitive and receptor-mediated regulation by
1,25-dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J Clin Invest
79(6):1700–5
40. D’Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F,
Panina-Bordignon P (Jan 1, 1998) Inhibition ofIL-12 production by 1,25-dihydroxyvitamin
D3. Involvement ofNF-kappaB downregulation in transcriptional repression of the p40 gene.
J Clin Invest 101(1):252–62
41. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (Aug,
1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvi-
tamin D3. Proc Natl Acad Sci USA 78(8):4990–4
42. Honma Y, Hozumi M, Abe E, Konno K, Fukushima M, Hata S, Nishii Y, DeLuca HF, Suda T
(Jan, 1983) 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival
time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80(1):201–4
43. Okamoto R, Akagi T, Koeffler HP (Jan, 2008) Vitamin D compounds and myelodysplastic
syndrome. Leuk Lymphoma 49(l):12–3
44. Koeffler HP, Aslanian N, O’Kelly J (Nov, 2005) Vitamin D(2) analog (Paricalcitol; Zemplar)
for treatment of myelodysplastic syndrome. Leuk Res 29(11):1259–62
45. Petrich A, Kahl B, Bailey H, Kim K, Turman N, Juckett M (Jan, 2008) Phase II study of
doxercalciferol for the treatment of myelodysplastic syndrome. Leuk Lymphoma
49(1):57–61
46. Hu ZB, Ma W, Uphoff CC, Lanotte M, Drexler HG (Nov, 1993) Modulation of gene expres-
sion in the acute promyelocytic leukemia cell line NB4. Leukemia 7(11):1817–23
47. Elstner E, Linker-Israeli M, Le J, Umiel T, Michl P, Said JW, Binderup L, Reed JC, Koeffler
HP (Jan 15, 1997) Synergistic decrease of clonal proliferation, induction of differentiation,
and apoptosis of acute promyelocytic leukemia cells after combined treatment with novel
20-epi vitamin D3 analogs and 9-cis retinoic acid. J Clin Invest 99(2):349–60
48. Godyn JJ, Xu H, Zhang F, Kolla S, Studzinski GP (Jan, 1994) A dual block to cell cycle
progression in HL60 cells exposed to analogues of vitamin D3. Cell Prolif 27(1):37–46
49. Kumagai T, O’Kelly J, Said JW, Koeffler HP (June 18, 2003) Vitamin D2 analog 19-nor-l,25-
dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.
J Natl Cancer Inst 95(12):896–905
50. Hisatake J, O’Kelly J, Uskokovic MR, Tomoyasu S, Koeffler HP (Apr 15, 2001) Novel
vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell
growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
Blood 97(8):2427–33
51. Koeffler HP (Oct, 1983) Induction of differentiation of human acute myelogenous leukemia
cells; therapeutic implications. Blood 62(4):709–21
52. Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussler MR (Feb, 1984)
1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell
line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98(2):391–8